ZyVersa Therapeutics Inc. (ZVSA) — Tangible Net Worth Ratio
ZyVersa Therapeutics Inc. (ZVSA) has a Tangible Net Worth Ratio of 99.7% as of June 2025. This metric is calculated by deducting intangible assets ($18.65K) from net assets ($6.10 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore ZVSA net assets growth trend to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
ZyVersa Therapeutics Inc. Tangible Net Worth Ratio (2022–2024)
This chart shows how ZyVersa Therapeutics Inc.'s Tangible Net Worth Ratio has changed across 3 annual periods from 2022 to 2024. As of June 2025, the ratio stands at 99.7%, reflecting net assets of $6.10 Million with intangible assets of $18.65K USD. For live market cap and overall valuation, see market cap of ZyVersa Therapeutics Inc..
Annual Tangible Net Worth Ratio for ZyVersa Therapeutics Inc. (2022–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for ZyVersa Therapeutics Inc. from 2022 to 2024, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See ZyVersa Therapeutics Inc. financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -119.0% | $8.52 Million | $18.65 Million | $20.60 Million | ▼ -50.6 pp |
| 2023 | -68.4% | $11.07 Million | $18.65 Million | $22.11 Million | ▼ -68.3 pp |
| 2022 | -0.1% | $99.99 Million | $100.09 Million | $118.51 Million | — |